This PCI white paper emphasizes the critical role of digital transformation for CDMOs (Contract Development and Manufacturing Organizations) in the pharmaceutical industry. Digitization enhances supply chain visibility, operational efficiency, and customer service. Key challenges include data silos, manual processes, and resistance to change. The paper highlights PCI’s platform, *pci | bridge™*, which enables real-time insights and automation. Best practices include customer-centric service, end-to-end data integration, digital recordkeeping, and cybersecurity. Future-focused CDMOs must embrace digital strategies to remain competitive, agile, and better aligned with pharmaceutical partners' evolving demands.

Join for free to read